Judith McMeekin, associate commissioner for FDA's Office of Regulatory Affairs (Stefani Reynolds/Pool via AP)

Out­go­ing reg­u­la­to­ry chief de­tails hir­ing and re­ten­tion chal­lenges for FDA in­spec­tors

The hir­ing of new FDA in­spec­tors con­tin­ues to be a chal­leng­ing task as the agency is los­ing in­spec­tors more quick­ly than it’s able to bring on new hires, said Judy McMeekin, as­so­ciate com­mis­sion­er for reg­u­la­to­ry af­fairs in the FDA’s Of­fice of Reg­u­la­to­ry Af­fairs (ORA), who’s re­tir­ing in June.

Speak­ing at a we­bi­nar host­ed by the Al­liance for a Stronger FDA, McMeekin said the “chal­lenges” in hir­ing and re­tain­ing staff are im­pact­ing the ORA’s abil­i­ty to con­duct in­spec­tions. She said most of the agency’s for­eign in­spec­tions are be­ing con­duct­ed by US-based in­ves­ti­ga­tors who are trav­el­ing to the for­eign sites three times per week.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.